| Literature DB >> 35160127 |
Christa Serban1,2, Diana Lungeanu3, Sergiu-David Bota1,2, Claudia C Cotca4, Meda Lavinia Negrutiu1,2, Virgil-Florin Duma2,5,6, Cosmin Sinescu1,2, Emanuela Lidia Craciunescu1,2.
Abstract
This systematic review and meta-analysis aimed at assessing the diagnostic accuracy of emerging technologies, such as laser fluorescence (LF), transillumination, light-emitting diode devices, optical coherence tomography (OCT), alternating current impedance spectroscopy, fluorescence cameras (FC), photo-thermal radiometry, and modulated luminescence technology. In vivo and in vitro results of such non-ionizing, non-invasive, and non-destructive methods' effectiveness in non-cavitated dentin caries detection are sometimes ambiguous. Following the PRISMA guidelines, 34 relevant research articles published between 2011-2021 were selected. The risk of bias was assessed with a tool tailored for caries diagnostic studies, and subsequent quantitative uni- and bi-variate meta-analysis was carried out in separate sub-groups according to the investigated surface (occlusal/proximal) and study setting (in vivo/in vitro). In spite of the high heterogeneity across the review groups, in vitro studies on LF and FC proved a good diagnostic ability for the occlusal surface, with area under the curve (AUC) of 0.803 (11 studies) and 0.845 (five studies), respectively. OCT studies reported an outstanding performance with an overall AUC = 0.945 (four studies). Promising technologies, such as OCT or FC VistaProof, still need well-designed and well-powered studies to accrue experimental and clinical data for conclusive medical evidence, especially for the proximal surface. Registration: INPLASY202210097.Entities:
Keywords: dental caries; diagnosis; laser fluorescence; non-cavitated dentin caries; occlusal caries; optical coherence tomography (OCT); permanent teeth; proximal caries; sensitivity; specificity
Year: 2022 PMID: 35160127 PMCID: PMC8837049 DOI: 10.3390/jcm11030674
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Search strategy used to search PubMed, EMBASE, and Medline.
| Search Category | Search Items |
|---|---|
| 1. | “dental caries” |
| AND | |
| 2. | “lasers” OR “fluorescence” OR fiber optics” OR optical coherence tomography” OR “light” OR “transillumination” OR “electrical conductivity” |
| AND | |
| 3. | “diagnosis” OR “detection” OR “validity”. |
Figure 1Flow diagram of the study selection process.
Figure 2Risk of bias assessment for the studies include in meta-analysis: (a) in vivo studies; (b) in vitro studies.
Meta-analytical results for the DIAGNOdent 2095 test. Only occlusal studies were identified and included in this analysis.
| Laser Fluorescence (LF) | |||
|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal |
| DIAGNOdent 2095 | In vivo | N | 2 |
| Univariate | |||
| I-square [%] | 0% | ||
| log DOR ± se; 95%CI | 2.79 ± 0.53 (1.75; 3.83) | ||
| R; 95%CI | – | ||
| DIAGNOdent 2095 | In vitro | N | 3 |
| Univariate | |||
| I-square [%] | 43.29% | ||
| log DOR ± se; 95%CI | 1.74 ± 0.44 (0.89; 2.6) | ||
| R; 95%CI | – | ||
| Bivariate | |||
| Tsens ± se; 95%CI | 0.14 ± 0.86 (−0.44; 0.71) | ||
| Tfpr ± se; 95%CI | −1.61 ± 0.27 (−2.13; −1.09) | ||
| Sensitivity; 95%CI | 0.53 (0.39; 0.67) | ||
| FPR; 95%CI | 0.17 (0.11; 0.25) | ||
| AUC | 0.745 | ||
| pAUC | 0.559 | ||
Abbreviations: AUC, area under the curve; CI, confidence interval; DOR, diagnostic odds ratio; FPR, false positive rate; pAUC, partial area under the curve; R, correlation coefficient between sensitivity and false positive rate; se, standard error of the estimate; Tfpr, log-transformed false positive rate; Tsens, log-transformed sensitivity.
Meta-analytical results for the DD pen test. The sub-group of 11 studies reporting occlusal in vitro results, with I-squared = 42.32%, underwent comprehensive meta-analysis (including graphs).
| Laser Fluorescence (LF) | ||||
|---|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal | Proximal |
| DD pen | In vivo | N | 3 | 2 |
| Univariate | ||||
| I-square [%] | 64.61% | 92.30% | ||
| log DOR ± se; 95%CI | 2.24 ± 0.54 (1.19; 3.3) | 1.27 ± 2.09 (−2.82; 5.36) | ||
| R; 95%CI | – | – | ||
| Bivariate | ||||
| Tsens ± se; 95%CI | 0.95 ± 0.86 (−0.05; 1.94) | – | ||
| Tfpr ± se; 95%CI | −1.24 ± 0.25 (−1.72; −0.75) | – | ||
| Sensitivity; 95%CI | 0.72 (0.49; 0.88) | – | ||
| FPR; 95%CI | 0.23 (0.15; 0.32) | – | ||
| AUC | 0.811 | – | ||
| pAUC | 0.672 | – | ||
| DD pen | In vitro | N | 11 | 3 |
| Univariate | ||||
| I-square [%] | 42.32% | 92.81% | ||
| log DOR ± se; 95%CI | 2.07 ± 0.26 (1.56; 2.58) | 3.67 ± 1.2 (1.32; 6.02) | ||
| R; 95%CI | 0.67 (0.12; 0.91) | – | ||
| Bivariate | ||||
| Tsens ± se; 95%CI | 0.75 ± 0.34 (0.08; 1.42) | 1.17 ± 0.86 (−0.52; 2.86) | ||
| Tfpr ± se; 95%CI | −1.28 ± 0.23 (−1.74; −0.82) | −2.4 ± 0.49 (−3.36; −1.44) | ||
| Sensitivity; 95%CI | 0.68 (0.52; 0.81) | 0.76 (0.37; 0.95) | ||
| FPR; 95%CI | 0.22 (0.15; 0.31) | 0.08 (0.03; 0.19) | ||
| AUC | 0.803 | 0.932 | ||
| pAUC | 0.702 | 0.743 | ||
Abbreviations: AUC, area under the curve; CI, confidence interval; DOR, diagnostic odds ratio; FPR, false positive rate; pAUC, partial area under the curve; R, correlation coefficient between sensitivity and false positive rate; se, standard error of the estimate; Tfpr, log-transformed false positive rate; Tsens, log-transformed sensitivity.
Figure 3Univariate summary plots for the three groups of index tests included in the comprehensive bivariate meta-analysis: LF DD pen occlusal, in vitro; FC VistaProof using optimal cut-off, in vitro; OCT overall. (a) Log DOR forest plots and random effects aggregate estimates. (b) Log DOR funnel plots to illustrate the publication bias as patterns of individual studies clustering around the mean effect.
Figure 4Bivariate summary ROC (sROC) curves for the three groups of index tests included in the comprehensive bivariate meta-analysis: LF DD pen occlusal, in vitro; FC VistaProof using optimal cut-off, in vitro; OCT overall. They also integrate the individual studies’ data in a summary bi-dimensional estimate and show its 95% prediction region.
Meta-analytical results for FC technology. The five-study sub-group reporting in vitro results by using optimal cut-off values for the VistaProof test, with I-squared = 26.32%, underwent comprehensive meta-analysis (including graphs).
| Fluorescence Camera (FC) | ||||
|---|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal | Occlusal |
| VistaProof | In vivo | N | 1 | – |
| Univariate | ||||
| I-square [%] | – | – | ||
| log DOR; 95%CI | 2.73 (1.50; 3.96) | – | ||
| R; 95%CI | – | – | ||
| VistaProof | In vitro | N | 3 | 5 |
| Univariate | ||||
| I-square [%] | 0% | 26.32% | ||
| log DOR ± se; 95%CI | 1.014 ± 0.63 (−0.22; 2.24) | 3.00 ± 0.40 (2.22; 3.78) | ||
| R; 95%CI | – | −0.55 (−0.97; 0.64) | ||
| Bivariate | ||||
| Tsens ± se; 95%CI | −1.63 ± 0.94 (−3.46; 0.21) | 2.14 ± 0.31 (1.53; 2.76) | ||
| Tfpr ± se; 95%CI | −2.51 ± 0.59 (−3.66; −1.36) | −0.73 ± 0.13 (−0.99; −0.47) | ||
| Sensitivity; 95%CI | 0.16 (0.03; 0.55) | 0.895 (0.82; 0.94) | ||
| FPR; 95%CI | 0.08 (0.03; 0.21) | 0.33 (0.27; 0.38) | ||
| AUC | 0.762 | 0.845 | ||
| pAUC | 0.253 | 0.871 | ||
| VistaCam iX | In vitro | N | 2 | 1 |
| Univariate | ||||
| I-square [%] | 0% | – | ||
| log DOR ± se; 95%CI | 2.35 ± 0.42 (1.54; 3.16) | 2.56 (1.56; 3.57) | ||
| R; 95%CI | – | – | ||
Abbreviations: AUC, area under the curve; CI, confidence interval; DOR, diagnostic odds ratio; FPR, false positive rate; pAUC, partial area under the curve; R, correlation coefficient between sensitivity and false positive rate; se, standard error of the estimate; Tfpr, log-transformed false positive rate; Tsens, log-transformed sensitivity.
Meta-analytical results for the optical coherence tomography (OCT) test. For this technology, supplemental comprehensive meta-analysis was conducted on the four identified studies (including graphs), irrespective of their review sub-group.
| Optical Coherence Tomography (OCT) | ||||
|---|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal | Proximal |
| OCT | In vivo | N | – | 1 |
| Univariate | ||||
| I-square [%] | – | – | ||
| log DOR; 95%CI | – | 4.49 (3.03; 5.95) | ||
| R; 95%CI | – | – | ||
| OCT | In vitro | N | 2 | 1 |
| Univariate | ||||
| I-square [%] | 0% | – | ||
| log DOR ± se; 95%CI | 2.98 ± 0.66 (1.69; 4.28) | 5.96 (4.22; 7.70) | ||
| R; 95%CI | – | – | ||
| OCT | In vivo | Occlusal & proximal | ||
| & in vitro | N | 4 | ||
| Univariate | ||||
| I-square [%] | 61.87% | |||
| log DOR ± se; 95%CI | 4.17 ± 0.71 (2.78; 5.56) | |||
| R; 95%CI | 0.37 (−0.92; 0.98) | |||
| Bivariate | ||||
| Tsens ± se; 95%CI | 1.36 ± 0.80 (−0.21; 2.94) | |||
| Tfpr ± se; 95%CI | −2.61 ± 0.64 (−3.87; −1.35) | |||
| Sensitivity; 95%CI | 0.80 (0.45; 0.95) | |||
| FPR; 95%CI | 0.07 (0.02; 0.21) | |||
| AUC | 0.945 | |||
| pAUC | 0.836 | |||
Abbreviations: AUC, area under the curve; CI, confidence interval; DOR, diagnostic odds ratio; FPR, false positive rate; pAUC, partial area under the curve; R, correlation coefficient between sensitivity and false positive rate; se, standard error of the estimate; Tfpr, log-transformed false positive rate; Tsens, log-transformed sensitivity.
Meta-analytical results for the near-infrared light transillumination (DIAGNOcam) test. Only univariate statistics could be determined, due to the limited number of studies in each sub-group.
| Near-InfraRed Light Transillumination (NIR-LT) | ||||
|---|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal | Proximal |
| DIAGNOcam | In vivo | N | 1 | 2 |
| Univariate | ||||
| I-square [%] | – | 93.66% | ||
| log DOR; 95%CI | 4.16 (2.10; 6.22) | 3.56 ± 2.44 (−1.22; 8.34) | ||
| R; 95%CI | – | – | ||
| DIAGNOcam | In vitro | N | – | 1 |
| Univariate | ||||
| I-square [%] | – | – | ||
| log DOR; 95%CI | – | 5.46 (3.59; 7.34) | ||
| R; 95%CI | – | – | ||
Abbreviations: AUC, area under the curve; CI, confidence interval; DOR, diagnostic odds ratio; FPR, false positive rate; pAUC, partial area under the curve; R, correlation coefficient between sensitivity and false positive rate; se, standard error of the estimate.
Meta-analytical results for the Midwest test. Only univariate statistics could be determined, due to the limited number of studies in each sub-group.
| Light-Emitting Diode-Based Device (LED) | ||||
|---|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal | Proximal |
| Midwest | In vivo | N | – | 1 |
| Univariate | ||||
| I-square [%] | – | – | ||
| log DOR; 95%CI | – | 1.71 (1.29; 2.13) | ||
| R; 95%CI | – | – | ||
| Midwest | In vitro | N | 2 | 2 |
| Univariate | ||||
| I-square [%] | 49.44% | 25.59% | ||
| log DOR ± se; 95%CI | 2.48 ± 0.53 (1.44; 3.52) | 1.67 ± 0.54 (0.62; 2.72) | ||
| R; 95%CI | – | – | ||
Abbreviations: AUC, area under the curve; CI, confidence interval; DOR, diagnostic odds ratio; FPR, false positive rate; pAUC, partial area under the curve; R, correlation coefficient between sensitivity and false positive rate; se, standard error of the estimate.
Meta-analytical results for the fibre-optic transillumination (FOTI) test. Only descriptive statistics could be determined, each for the single study in each sub-group.
| Fiber-Optic Transillumination (FOTI) | ||||
|---|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal | Proximal |
| FOTI | In vivo | N | – | 1 |
| Univariate | ||||
| I-square [%] | – | – | ||
| log DOR; 95%CI | – | 2.46 (2.06; 2.87) | ||
| R; 95%CI | – | – | ||
| FOTI | In vitro | N | 1 | 1 |
| Univariate | ||||
| I-square [%] | – | – | ||
| log DOR; 95%CI | 3.78 (2.63; 4.93) | 2.28 (0.81; 3.75) | ||
| R; 95%CI | – | – | ||
Abbreviations: CI, confidence interval; DOR, diagnostic odds ratio.
Meta-analytical results for the quantitative light-induced fluorescence (QLF) Inspektor Pro test.
| Quantitative Light-Induced Fluorescence (QLF) | ||||
|---|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal | Proximal |
| QLF Inspektor Pro | In vitro | N | 3 | 1 |
| Univariate | ||||
| I-square [%] | 0% | – | ||
| log DOR ± se; 95%CI | 2.75 ± 0.31 (2.15; 3.35) | 2.55(1.27; 3.83) | ||
| R; 95%CI | – | – | ||
| Bivariate | ||||
| Tsens ± se; 95%CI | 1.66 ± 0.39 (0.90; 2.41) | – | ||
| Tfpr ± se; 95%CI | −1.18 ± 0.34 (−1.85; −0.51) | – | ||
| Sensitivity; 95%CI | 0.84 (0.71; 0.92) | – | ||
| FPR; 95%CI | 0.24 (0.14; 0.38) | – | ||
| AUC | 0.873 | – | ||
| pAUC | 0.854 | – | ||
Abbreviations: AUC, area under the curve; CI, confidence interval; DOR, diagnostic odds ratio; FPR, false positive rate; pAUC, partial area under the curve; R, correlation coefficient between sensitivity and false positive rate; se, standard error of the estimate; Tfpr, log-transformed false positive rate; Tsens, log-transformed sensitivity.
Meta-analytical results for the LIF test. Only partial univariate statistics could be determined, due to the limited number of studies.
| Light-Induced Fluorescence (LIF) | |||
|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal |
| LIF | In vitro | N | 2 |
| Univariate | |||
| I-square [%] | 0% | ||
| log DOR ± se; 95%CI | 3.52 ± 0.50 (2.54; 4.50) | ||
| R; 95%CI | – | ||
Abbreviations: CI, confidence interval; DOR, diagnostic odds ratio; se, standard error of the estimate.
Descriptive results for the alternating current impedance spectroscopy (ACIS) technology, CarieScan PRO test.
| Alternating Current Impedance Spectroscopy (ACIS) | |||
|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal |
| CarieScan PRO | In vivo | N | 1 |
| Univariate | |||
| I-square [%] | – | ||
| log DOR; 95%CI | 3.56 (2.20; 4.91) | ||
| R; 95%CI | – | ||
| CarieScan PRO | In vitro | N | 1 |
| Univariate | |||
| I-square [%] | – | ||
| log DOR; 95%CI | 1.45 (−0.99; 3.89) | ||
| R; 95%CI | – | ||
Abbreviations: CI, confidence interval; DOR, diagnostic odds ratio.
Descriptive results for the photo-thermal radiometry and modulated luminescence (PTR-LUM) technology, Canary System test.
| PhotoThermal Radiometry and Modulated Luminescence (PTR-LUM) | |||
|---|---|---|---|
| Index Test | In Vivo/ | Meta-Analytical Statistics | Occlusal |
| Canary System | In vitro | N | 1 |
| Univariate | |||
| I-square [%] | – | ||
| log DOR; 95%CI | 1.55 (0.32; 2.78) | ||
| R; 95%CI | – | ||
Abbreviations: CI, confidence interval; DOR, diagnostic odds ratio.